EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Single‐Cell Transcriptomics Uncover EEF1A1‐Driven Ubiquitination Dysregulation in T Cell Exhaustion and SLE Pathogenesis via STAT1‐Mediated Th1/Th2 Imbalance

Lu Xing, Tao Wu, Hongyan Xu, Shuyun Yang, Chunyan Luan, Yinde Xu, Yi Mao, Xiaolan Li

Mediators of Inflammation · 2025-01 · 2025 (1)

DOI: 10.1155/mi/3708640 ↗
AbstractBibliografische Angaben

Abstract

Background Systemic lupus erythematosus (SLE) is a complex autoimmune disorder marked by immune dysregulation and multiorgan involvement. This study investigates the role of the ubiquitination‐related gene EEF1A1 in SLE pathogenesis, focusing on T cell dysfunction. Methods Single‐cell RNA sequencing (scRNA‐seq) data from the GSE135779 dataset was analyzed to characterize the cellular composition of SLE samples. Clustering analysis identified 15 T cell subpopulations, with seven clusters notably depleted in SLE. Trajectory analysis indicated progressive transcriptional dysregulation during T cell differentiation. High‐dimensional weighted gene coexpression network analysis (hdWGCNA) and LASSO regression highlighted EEF1A1 as a key ubiquitination‐related hub gene. EEF1A1 expression was significantly elevated in SLE T cells, while its ubiquitinated form was reduced, suggesting impaired proteasomal degradation. Results Functional assays demonstrated that EEF1A1 overexpression enhances STAT1 phosphorylation (p‐STAT1) without altering total STAT1 protein levels, leading to T cell dysfunction. In vitro and in vivo experiments revealed that EEF1A1 overexpression skews the T helper 1 (Th1)/T helper 2 (Th2) balance towards a Th1‐dominant phenotype. In MRL/lpr mouse models, EEF1A1 overexpression exacerbated renal pathology, including increased proteinuria and immune complex deposition. Conclusions These findings suggest that EEF1A1 contributes to SLE pathogenesis by promoting STAT1‐mediated T cell dysfunction and Th1/Th2 imbalance. EEF1A1 emerges as a potential biomarker and therapeutic target, offering new insights into the post‐translational regulatory mechanisms underlying SLE.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →